The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Per the FDA, the recalled Cal Yee’s (or Cal Yee Farm branded) products were packaged in clear plastic zippered pouches in ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...